Bio-Path Holdings is an antisense DNA therapeutics founded in 2011 by Peter Nielsen.
Antisense DNA therapeutics
An oncology-focused biotechnology company leveraging its innovative DNAbilize®
platform technology to deliver DNA therapeutics directly to cancer cells